Open ‐Label Non‐Mandatory Transitioning From Originator Etanercept to Biosimilar SB4: 6‐Month Results From a Controlled Cohort Study

Arthritis&Rheumatology,Volume 0, Issue ja, -Not available-.

Source: Arthritis and Rheumatology - April 2, 2018 Category: Rheumatology Authors: Lieke Tweehuysen , Victor JB Huiskes , Bart JF van den Bemt , Johanna E Vriezekolk , Steven Teerenstra , Frank HJ van den Hoogen , Cornelia H van den Ende , Alfons A den Broeder Source Type: research